Histological Effects of Subepithelial Vaginal Platelet-Rich Plasma for Women With Genitourinary Syndrome of Menopause and Pelvic Organ Prolapse

Single-blind, single-arm trial of platelet-rich plasma in genitourinary syndrome of menopause (GSM), sponsored by National and Kapodistrian University of Athens. Primary endpoints: Epithelial thickness at 8 weeks and Vascular density of the lamina propria at 8 weeks. Started Apr 2023; status: completed.